NEWS
UPDATES
Naschitz Brandes Amir advises MeMed on signing a strategic partnership with Italian Biotech giant DiaSorin.
08 September 2020
Naschitz Brandes Amir advises MeMed, a leader in host response-based diagnostics, on signing a strategic partnership with Italian Biotech giant DiaSorin to market and develop an innovative diagnostic test that accurately distinguishes between viral and bacterial infections. The company is represented by high-tech partners Arnon Samburski and Daniella Ben Shalom.